Literature DB >> 23578666

The role of citrullination of an immunodominant proteoglycan (PG) aggrecan T cell epitope in BALB/c mice with PG-induced arthritis.

Petra Misják1, Szilvia Bősze, Kata Horváti, Mária Pásztói, Krisztina Pálóczi, Marianna C Holub, Ferenc Szakács, Borbála Aradi, Bence György, Tamás G Szabó, György Nagy, Tibor T Glant, Katalin Mikecz, András Falus, Edit I Buzás.   

Abstract

The P70-84 peptide (also called 5/4E8 epitope) of the human cartilage proteoglycan (PG) aggrecan is the dominant/arthritogenic epitope in both humans and arthritis-prone BALB/c mice (PG-induced arthritis, PGIA). An elevated T cell reactivity was demonstrated to a citrullinated version of the P70-84 epitope in most of the patients with rheumatoid arthritis (RA). The goal of this study was to understand better how a T cell epitope, if citrullinated, may affect antigenicity/arthritogenicity in PGIA, a murine model of RA. T cell reactivity to differentially citrullinated versions of either the human PG aggrecan P70-84 peptide or the corresponding mouse sequence was assessed in peptide or aggrecan-immunized and arthritic BALB/c mice as well as in T cell receptor transgenic mice specific for peptide P70-84 sequence. Peripheral T cell responses were induced by priming BALB/c mice with either the human wild-type or its citrullinated versions. Unexpectedly, priming with the citrullinated self-peptide induced a higher T cell response compared to the wild-type sequence (p<0.001), and the citrullination of the human peptide abolished T cell reactivity in PGIA. Our data suggest that T cells reactive to the citrullinated P70-84 peptide escaped thymic selection and are present in the peripheral T cell repertoire. Results of this study provide evidence that citrullination of an immunodominant T cell epitope may substantially alter, either increase or abolish, T cell recognition at the periphery in an experimental model of arthritis.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23578666     DOI: 10.1016/j.imlet.2013.03.005

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  9 in total

Review 1.  Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis.

Authors:  Kenneth S Rosenthal; Katalin Mikecz; Harold L Steiner; Tibor T Glant; Alison Finnegan; Roy E Carambula; Daniel H Zimmerman
Journal:  Expert Rev Vaccines       Date:  2015-03-18       Impact factor: 5.217

Review 2.  Of mice and men: how animal models advance our understanding of T-cell function in RA.

Authors:  Tamás Kobezda; Sheida Ghassemi-Nejad; Katalin Mikecz; Tibor T Glant; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2014-01-07       Impact factor: 20.543

3.  Reduced TCR-dependent activation through citrullination of a T-cell epitope enhances Th17 development by disruption of the STAT3/5 balance.

Authors:  Christopher Tibbitt; Jane Falconer; Jeroen Stoop; Willem van Eden; John H Robinson; Catharien M U Hilkens
Journal:  Eur J Immunol       Date:  2016-07       Impact factor: 5.532

4.  Mesenchymal Stem Cell-Conditioned Medium Reduces Disease Severity and Immune Responses in Inflammatory Arthritis.

Authors:  Alasdair G Kay; Grace Long; George Tyler; Andrei Stefan; Stephen J Broadfoot; Anna M Piccinini; Jim Middleton; Oksana Kehoe
Journal:  Sci Rep       Date:  2017-12-21       Impact factor: 4.379

5.  In search of chondrocyte-specific antigen.

Authors:  Anna Osiecka-Iwan; Piotr Skopinski; Dorota M Radomska-Lesniewska; Anna Hyc
Journal:  Cent Eur J Immunol       Date:  2018-06-30       Impact factor: 2.085

6.  Therapeutic Effects of Hypoxic and Pro-Inflammatory Priming of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Inflammatory Arthritis.

Authors:  Alasdair G Kay; Kane Treadwell; Paul Roach; Rebecca Morgan; Rhys Lodge; Mairead Hyland; Anna M Piccinini; Nicholas R Forsyth; Oksana Kehoe
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

7.  Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.

Authors:  Adrienn Markovics; Tímea Ocskó; Robert S Katz; Edit I Buzás; Tibor T Glant; Katalin Mikecz
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

8.  Characterization and Localization of Citrullinated Proteoglycan Aggrecan in Human Articular Cartilage.

Authors:  Tibor T Glant; Timea Ocsko; Adrienn Markovics; Zoltan Szekanecz; Robert S Katz; Tibor A Rauch; Katalin Mikecz
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

9.  Vaccination by Two DerG LEAPS Conjugates Incorporating Distinct Proteoglycan (PG, Aggrecan) Epitopes Provides Therapy by Different Immune Mechanisms in a Mouse Model of Rheumatoid Arthritis.

Authors:  Daniel H Zimmerman; Katalin Mikecz; Adrienn Markovics; Roy E Carambula; Jason C Ciemielewski; Daniel M Toth; Tibor T Glant; Ken S Rosenthal
Journal:  Vaccines (Basel)       Date:  2021-05-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.